Some benefits of using Cyberknife over traditional radiation include less radiation damage to normal tissue surrounding the cancerous location within the body, according to Boston Medical Center. Cyberknife treatment can be delivered in fewer treatments than traditional radiation, requires no immobilization devices and yields fewer side effects, states Cyberknife.
Cyberknife is a noninvasive treatment for benign and malignant tumors throughout the body, including the brain and lungs. With Cyberknife, radiation beams can be directed from any direction within a submillimeter of accuracy so as to target tumors. Traditional radiation delivers radiation beams from a limited number of directions, requiring low doses over a wide area of the body, which damages healthy tissue, according to the Boston Medical Center.
The precision with which Cyberknife can target radiation beams at tumors means higher doses are possible. Higher doses of targeted radiation and less damage to healthy tissue effectively decreases treatment time, claims Cyberknife. The low doses typical of traditional radiation treatments can potentially extend treatment time over weeks and months, whereas the course of a Cyberknife treatment can be completed in one to five visits, states the Boston Medical Center.
Although mild fatigue and nausea are possible, the relative swiftness and focused intensity of Cyberknife treatments produces few to no side effects, states Cyberknife. Patients undergoing Cyberknife do not have to be contained within head or a body frames associated with traditional radiation therapy, especially stereotactic radiosurgery, according to the Boston Medical Center.